How AI and QSAR Modeling Accelerate Ligand-Based Drug Design - News-Medical.Net
PushButton AI Team ·
How AI and QSAR Modeling Accelerate Ligand-Based Drug Design - News-Medical.Net
Pharmaceutical companies spent decades testing thousands of molecules hoping one would work. Now AI narrows that to dozens — before a single lab test runs.
That's not hype. That's pattern recognition
Pharmaceutical companies spent decades testing thousands of molecules hoping one would work. Now AI narrows that to dozens — before a single lab test runs.
That's not hype. That's pattern recognition at scale doing what humans can't.
Here's why this matters to you, even if you'll never touch a test tube.
The same principle applies to your business. AI isn't magic — it's good at finding patterns in large amounts of data and predicting which option is most likely to work. Drug researchers figured this out by starting small: one problem, one data set, measurable results.
That's the part most consultants skip. They sell you the whole vision instead of the first win.
You don't need an AI overhaul. You need to identify one repetitive decision in your business — a quote, a forecast, a customer response — where you already have historical data sitting in a spreadsheet. That's your starting point. That's where AI earns its keep fast.
Start there. Prove it works on something small. Then expand.
What's one decision in your business you make the same way every week — one that AI could probably handle better than a spreadsheet?
